The Clinical Significance of Tumor-Associated Antigen RCAS1 Expression in the Normal, Hyperplastic, and Malignant Uterine Endometrium
Authors:
- 1 December 2000
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (3) , 424-429
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (11671626)
This publication has 7 references indexed in Scilit:
- Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1Nature Medicine, 1999
- Isolation of Estrogen-Responsive Genes with a CpG Island LibraryMolecular and Cellular Biology, 1998
- A novel tumor-associated antigen expressed in human uterine and ovarian carcinomasCancer, 1996
- ESTABLISHMENT OF A NEW HUMAN UTERINE CERVICAL ADENOCARCINOMA CELL-LINE, SISO, AND ITS REACTIVITY TO ANTICANCER REAGENTSInternational Journal of Oncology, 1995
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983
- The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase TechnicsAmerican Journal of Clinical Pathology, 1981